We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Factors Setting the Tone for Rite Aid's (RAD) Q1 Earnings
Read MoreHide Full Article
Rite Aid Corporation is scheduled to report first-quarter fiscal 2021 results on Jun 25, before the opening bell. Notably, the company has a positive earnings surprise of 191.4%, on average, for the trailing four quarters.
The Zacks Consensus Estimate for the company’s fiscal first-quarter earnings is pegged at a loss of 54 cents per share, which indicates a significant decline from a loss of 14 cents reported in the year-ago quarter. Notably, the consensus mark remained stable in the past 60 days. For revenues, the consensus mark is pegged at $5,599 million, suggesting growth of 4.2% from the year-ago quarter’s reported figure.
Factors to Note
Rite Aid has been gaining from its efforts to provide home delivery services amid the COVID-19 crisis at zero costs to those with an eligible prescription. Further, it is offering pick-up services for prescriptions and over-the-counter products, with a drive-through option available at more than 50% of its retail locations. In its latest move to enhance customer experience, Rite Aid launched a pay-and-go facility in a bid to expedite the prescription pick-up service in both stores and drive through. Moreover, the company is partnering with Instacart and on track to introduce more convenient delivery options for customers who shop from stores. Additionally, the company introduced an Amazon pickup solution at every Rite Aid store. Management is also on track to introduce self-checkout across 400 more stores by fiscal 2021. These moves are expected to have improved traffic and hence, contribute to the company’s top line in the first quarter.
Moreover, management remains focused on strengthening its foothold in mid-market PBM, bringing innovation across its retail and mail-order pharmacy channels, enhancing the in-store experience by curated digital offerings, improving merchandises and rebranding its image with a new logo. Notably, the company has been witnessing a significant uptick in PBM, in terms of mail orders, as customers are increasingly hoarding 90-day refills in the wake of COVID-19. Alongside this, rising demand for prescription files is likely to help the company double its pharmacy business in the near term.
Apart from these, the company has been investing in the expansion of EnvisionRxOptions, especially its services, technologies and clinical offerings. The company has also partnered with UNFI for introducing the Wild Harvest brand in Rite Aid stores. Such well-chalked endeavors have been boosting the company’s wellness offerings.
However, it has been witnessing weak adjusted EBITDA for the past few quarters, which remains a threat to the bottom line in the quarter under review. Further, any decline in front-end sales and supply-chain disruptions stemming from the ongoing pandemic might have hurt its fiscal first-quarter results.
Our proven model does not conclusively predict an earnings beat for Rite Aid this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Rite Aid has a Zacks Rank #3 but an Earnings ESP of 0.00% makes surprise prediction difficult.
Stocks Poised to Beat Earnings Estimates
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat:
CarMax (KMX - Free Report) has an Earnings ESP of +59.70%. It currently carries a Zacks Rank #3.
Kimberly-Clark Corporation (KMB - Free Report) currently has an Earnings ESP of +1.78% and a Zacks Rank #3.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Image: Shutterstock
Factors Setting the Tone for Rite Aid's (RAD) Q1 Earnings
Rite Aid Corporation is scheduled to report first-quarter fiscal 2021 results on Jun 25, before the opening bell. Notably, the company has a positive earnings surprise of 191.4%, on average, for the trailing four quarters.
The Zacks Consensus Estimate for the company’s fiscal first-quarter earnings is pegged at a loss of 54 cents per share, which indicates a significant decline from a loss of 14 cents reported in the year-ago quarter. Notably, the consensus mark remained stable in the past 60 days. For revenues, the consensus mark is pegged at $5,599 million, suggesting growth of 4.2% from the year-ago quarter’s reported figure.
Factors to Note
Rite Aid has been gaining from its efforts to provide home delivery services amid the COVID-19 crisis at zero costs to those with an eligible prescription. Further, it is offering pick-up services for prescriptions and over-the-counter products, with a drive-through option available at more than 50% of its retail locations. In its latest move to enhance customer experience, Rite Aid launched a pay-and-go facility in a bid to expedite the prescription pick-up service in both stores and drive through. Moreover, the company is partnering with Instacart and on track to introduce more convenient delivery options for customers who shop from stores. Additionally, the company introduced an Amazon pickup solution at every Rite Aid store. Management is also on track to introduce self-checkout across 400 more stores by fiscal 2021. These moves are expected to have improved traffic and hence, contribute to the company’s top line in the first quarter.
Moreover, management remains focused on strengthening its foothold in mid-market PBM, bringing innovation across its retail and mail-order pharmacy channels, enhancing the in-store experience by curated digital offerings, improving merchandises and rebranding its image with a new logo. Notably, the company has been witnessing a significant uptick in PBM, in terms of mail orders, as customers are increasingly hoarding 90-day refills in the wake of COVID-19. Alongside this, rising demand for prescription files is likely to help the company double its pharmacy business in the near term.
Apart from these, the company has been investing in the expansion of EnvisionRxOptions, especially its services, technologies and clinical offerings. The company has also partnered with UNFI for introducing the Wild Harvest brand in Rite Aid stores. Such well-chalked endeavors have been boosting the company’s wellness offerings.
However, it has been witnessing weak adjusted EBITDA for the past few quarters, which remains a threat to the bottom line in the quarter under review. Further, any decline in front-end sales and supply-chain disruptions stemming from the ongoing pandemic might have hurt its fiscal first-quarter results.
Rite Aid Corporation Price and EPS Surprise
Rite Aid Corporation price-eps-surprise | Rite Aid Corporation Quote
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Rite Aid this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Rite Aid has a Zacks Rank #3 but an Earnings ESP of 0.00% makes surprise prediction difficult.
Stocks Poised to Beat Earnings Estimates
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat:
Fastenal Company (FAST - Free Report) has an Earnings ESP of +5.88%. It has a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
CarMax (KMX - Free Report) has an Earnings ESP of +59.70%. It currently carries a Zacks Rank #3.
Kimberly-Clark Corporation (KMB - Free Report) currently has an Earnings ESP of +1.78% and a Zacks Rank #3.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>